Latest Samrat Pharmachem stock price
Samrat Pharmachem P/E Ratio
SAMRATPH • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
9.89
Low Valuation
Very Low - Potentially undervalued or facing challenges
Current Valuation Metrics
P/E Ratio
9.89
Current Price
₹227.75
EPS (TTM)
₹23.02
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
49.35
Sector Median
26.63
Sector Rank
#10 of 140
Sector Percentile
7.1%
Key P/E Ratio Insights for Samrat Pharmachem
- Stock appears undervalued with PE of 9.89, suggesting potential buying opportunity
- Trading at discount to sector average PE of 49.35
View the SAMRATPH equity price for detailed stock performance.
Related Pages for Samrat Pharmachem
Additional stock information and data for SAMRATPH
Sector P/E Ratio Comparison
Comparing Samrat Pharmachem with other companies in Healthcare sector
Sector Average
49.35
Sector Median
26.63
Lowest P/E
0.97
Highest P/E
993.26
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| Galaxy Medicare | GML | 7.25 | ₹24 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Zenith Drugs | ZENITHDRUG | 7.9 | ₹76 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Vasundhara Rasayans | VRL | 9.97 | ₹37 | Low |